# Study of Naltrexone-Induced Blockade of Antidepressant Effects

> **NCT04322526** · PHASE4 · COMPLETED · sponsor: **Marta Peciña, MD PhD** · enrollment: 25 (actual)

## Conditions studied

- Depression
- Major Depressive Disorder

## Interventions

- **DRUG:** Naltrexone 50 Mg Oral Tablet
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04322526
- **Lead sponsor:** Marta Peciña, MD PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-01
- **Primary completion:** 2018-07-15
- **Final completion:** 2018-07-15
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04322526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04322526, "Study of Naltrexone-Induced Blockade of Antidepressant Effects". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT04322526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*